, Volume 13 Issue 4 Previous Issue   Next Issue
    For Selected: View Abstracts Toggle Thumbnails
    REVIEW
    Terpenes extracted from marine sponges with antioxidant activity: a systematic review   Collect
    Cintia Cristina Santi Martignago, Beatriz Soares-Silva, Julia Risso Parisi, Lais Caroline Souza e Silva, Renata Neves Granito, Alessandra Mussi Ribeiro, Ana Cláudia Muniz Renno, Lorena Ramos Freitas de Sousa, Anna Caroline Campos Aguiar
    Natural Products and Bioprospecting. 2023, 13 (4): 23-23.   DOI: 10.1007/s13659-023-00387-y
    Abstract ( 1280 )   HTML ()     PDF (1828KB) ( 1654 )  
    Marine biodiversity has emerged as a very promising resource of bioactive compounds and secondary metabolites from different sea organisms. The sponge’s secondary metabolites demonstrated various bioactivities and potential pharmacological properties. This systematic review of the literature focuses on the advances achieved in the antioxidant potential of marine sponges in vitro. The review was performed in accordance with PRISMA guidelines. The main inclusion criterion for analysis was articles with identification of compounds from terpene classes that demonstrate antioxidant activity in vitro. Searching in three different databases, two hundred articles were selected. After screening abstracts, titles and evaluating for eligibility of manuscripts 14 articles were included. The most performed analyzes to detect antioxidant activity were scavenging activity 2,2-diphenyl-1-picrylhydrazyl (DPPH) and measurement of intracellular reactive oxygen species (ROS). It was possible to identify 17 compounds of the terpene class with pronounced antioxidant activity in vitro. Scientific evidence of the studies included in this review was accessed by the GRADE analysis. Terpenes play an important ecological role, moreover these molecules have a pharmaceutical and industrial application.
    References | Related Articles | Metrics
    EDITORIAL
    Unleashing the potential: further enhancing the impact of Natural Products and Bioprospecting   Collect
    Ji-Kai Liu, Xiao-dong Luo, Ling Zhang, Ying Zhang
    Natural Products and Bioprospecting. 2023, 13 (4): 24-24.   DOI: 10.1007/s13659-023-00388-x
    Abstract ( 1369 )   HTML ()     PDF (723KB) ( 1534 )  
    Related Articles | Metrics
    ORIGINAL ARTICLES
    Quality assurance of postharvest grapes against Botrytis cinerea by terbinafine   Collect
    Yun Zhao, Qiong Jin, Zi-Jiao Wang, Xing-Yu Tao, Xiao-Dong Luo
    Natural Products and Bioprospecting. 2023, 13 (4): 25-25.   DOI: 10.1007/s13659-023-00389-w
    Abstract ( 1344 )   HTML ()     PDF (1769KB) ( 1613 )  
    Worldwide, fruit is an indispensable treasure house of nutrition for human beings, occupying a vital position of human diet. Postharvest fruit storage requires efficient antifungal agents to control Botrytis cinerea, which is a vital postharvest disease affecting fruit and leading to enormous losses. However, with the enormous abuse of existing antifungal drugs, the problem of drug-resistant fungi is imminent, making the controlling diseases caused by pathogenic fungi even more challenging. Drug repurposing is an efficient alternative method, we evaluated a well-known antifungal chemical, terbinafine, against the agricultural pathogen, B. cinerea in vitro, as a result, terbinafine showed strong antifungal activity. Furthermore, the in vivo antifungal activity of terbinafine was evaluated, the results showed that terbinafine could reduce the decay area on grapes. Terbinafine could disrupt the cell membrane integrity, increase cell membrane permeability, and eventual cell death of B. cinerea. In addition, terbinafine reduced decay incidence, and weight loss and maintained the soluble solids, titratable acidity, ascorbic acid, total phenolic, and malondialdehyde content during the storage period of grapes. Overall, terbinafine could be an antifungal preservative for postharvest table grapes fresh-keeping.
    References | Related Articles | Metrics
    Two pyrrole acids isolated from Phyllanthus emblica L. and their bioactivities   Collect
    Shu-Hui Wang, Cong Guo, Wen-Jin Cui, Qing-Xia Xu, Jun Zhang, Jin-Zhu Jiang, Yan Liu, Sha Chen, Chang Chen, Jin-Tang Cheng, An Liu
    Natural Products and Bioprospecting. 2023, 13 (4): 26-26.   DOI: 10.1007/s13659-023-00393-0
    Abstract ( 1388 )   HTML ()     PDF (1882KB) ( 1621 )  
    An undescribed pyrrole acid, 1-(4'-methoxy-4'-oxobutyl)-1 H-pyrrole-2,5-dicarboxylic acid (1) and one known pyrrole acid (2) were isolated from the fruits of Phyllanthus emblica. The structures of these compounds were elucidated via the comprehensive analyses of IR, HRESIMS, 1D and 2D spectroscopic data. A series of biological assays revealed that compounds 1 and 2 could inhibit LPS-induced over-production of nitric oxide (NO), interleukin-6 (IL-6), monocyte chemotactic protein 1 (MCP-1) and tumor necrosis factor-α (TNF-α) by reducing the phosphorylation of extracellular regulated protein kinases (ERK) and c-Jun N-terminal kinases (JNK) in RAW 264.7 cells. Additionally, compounds 1 and 2 were found to reduce lipid deposition and increase the mRNA expression of ATP-binding cassette transporter A1 in oxidized low-density lipoprotein-treated RAW264.7 macrophages.
    References | Related Articles | Metrics
    Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells   Collect
    Meichen Wang, Leilei Liang, Rong Wang, Shutao Jia, Chang Xu, Yuting Wang, Min Luo, Qiqi Lin, Min Yang, Hongyu Zhou, Dandan Liu, Chen Qing
    Natural Products and Bioprospecting. 2023, 13 (4): 27-27.   DOI: 10.1007/s13659-023-00392-1
    Abstract ( 1330 )   HTML ()     PDF (3869KB) ( 1569 )  
    DNA topoisomerases are essential nuclear enzymes in correcting topological DNA errors and maintaining DNA integrity. Topoisomerase inhibitors are a significant class of cancer chemotherapeutics with a definite curative effect. Natural products are a rich source of lead compounds for drug discovery, including anti-tumor drugs. In this study, we found that narciclasine (NCS), an amaryllidaceae alkaloid, is a novel inhibitor of topoisomerase I (topo I). Our data demonstrated that NCS inhibited topo I activity and reversed its unwinding effect on p-HOT DNA substrate. However, it had no obvious effect on topo II activity. The molecular mechanism of NCS inhibited topo I showed that NCS did not stabilize topo-DNA covalent complexes in cells, indicating that NCS is not a topo I poison. A blind docking result showed that NCS could bind to topo I, suggesting that NCS might be a topo I suppressor. Additionally, NCS exhibited a potent anti-proliferation effect in various cancer cells. NCS arrested the cell cycle at G2/M phase and induced cell apoptosis. Our study reveals the antitumor mechanisms of NCS and provides a good foundation for the development of anti-cancer drugs based on topo I inhibition.
    References | Related Articles | Metrics
    SHORT COMMUNICATION
    Three new amide derivatives from the fungus Alternaria brassicicola   Collect
    Fengli Li, Saisai Gu, Sitian Zhang, Shuyuan Mo, Jieru Guo, Zhengxi Hu, Yonghui Zhang
    Natural Products and Bioprospecting. 2023, 13 (4): 28-28.   DOI: 10.1007/s13659-023-00391-2
    Abstract ( 1371 )   HTML ()     PDF (978KB) ( 1588 )  
    Three new amide derivatives (alteralkaloids A–C, 13) and three known alkaloids (46) were afforded after phytochemical investigation of fungus Alternaria brassicicola. The structures of these compounds were confirmed by NMR spectroscopic and HRESIMS data. Furthermore, the absolute configuration of 1 was determined using the single-crystal X-ray diffraction analysis. Compounds 13 belong to a class of amide derivatives that have not been found in nature before, sharing the same characteristic signals of the butyl moiety and amide group. These isolated compounds mentioned above were tested for the cytotoxic activity.
    References | Related Articles | Metrics
    ORIGINAL ARTICLES
    Puerarin alleviates sleep disorders in aged mice related to repairing intestinal mucosal barrier   Collect
    Qing Tao, Jinhua Zhang, Qiao liang, Shiyu Song, Shuxia Wang, Xiaoming Yao, Qian Gao, Lei Wang
    Natural Products and Bioprospecting. 2023, 13 (4): 29-29.   DOI: 10.1007/s13659-023-00390-3
    Abstract ( 1359 )   HTML ()     PDF (2598KB) ( 1547 )  
    More and more evidence suggests that puerarin, a potential remedy for gut inflammation, may have an ameliorative effect on sleep disturbances. However, the relationship between puerarin and sleep disruption has not been extensively researched. This study aims to explore the role and mechanisms of puerarin in improving sleep disorders. We established a light-induced sleep disorder model in mice and assessed the effects of puerarin on cognitive behavior using open field and water maze tests. Pathological detection demonstrated that sleep disturbances resulted in observable damage to the liver, lung, and kidney. Puerarin reversed multi-organ damage and inflammation. Further, puerarin activated paneth cells, resulting in increased lysozyme and TGF-β production, and stimulating intestinal stem cell proliferation. Puerarin also effectively inhibited the expression of F4/80, iNOS, TNF-α, and IL-1β in the small intestine, while it increased Chil3, CD206, and Arg-1 levels. Moreover, puerarin treatment significantly decreased P-P65, TLR4, Bcl-xl, and cleaved caspase-3 protein levels while increasing barrier protein levels, including ZO-1, Occludin, Claudin 1 and E-cadherin suggesting a reduction in inflammation and apoptosis in the gut. Overall, puerarin diminished systemic inflammation, particularly intestinal inflammation, and enhanced intestinal barrier integrity in mice with sleep disorders. Our findings suggest a potential new therapeutic pathway for sleep disorders.
    References | Related Articles | Metrics
    Optimized solubility and bioavailability of genistein based on cocrystal engineering   Collect
    Zhipeng Wang, Qi Li, Qi An, Lixiang Gong, Shiying Yang, Baoxi Zhang, Bin Su, Dezhi Yang, Li Zhang, Yang Lu, Guanhua Du
    Natural Products and Bioprospecting. 2023, 13 (4): 30-30.   DOI: 10.1007/s13659-023-00397-w
    Abstract ( 1268 )   HTML ()     PDF (6645KB) ( 1557 )  
    With various potential health-promoting bioactivities, genistein has great prospects in treatment of a series of complex diseases and metabolic syndromes such as cancer, diabetes, cardiovascular diseases, menopausal symptoms and so on. However, poor solubility and unsatisfactory bioavailability seriously limits its clinical application and market development. To optimize the solubility and bioavailability of genistein, the cocrystal of genistein and piperazine was prepared by grinding assisted with solvent based on the concept of cocrystal engineering. Using a series of analytical techniques including single-crystal X-ray diffraction, powder X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry and thermogravimetric analysis, the cocrystal was characterized and confirmed. Then, structure analysis on the basis of theoretical calculation and a series of evaluation on the stability, dissolution and bioavailability were carried out. The results indicated that the cocrystal of genistein and piperazine improved the solubility and bioavailability of genistein. Compared with the previous studies on the cocrystal of genistein, this is a systematic and comprehensive investigation from the aspects of preparation, characterization, structural analysis, stability, solubility and bioavailability evaluation. As a simple, efficient and green approach, cocrystal engineering can pave a new path to optimize the pharmaceutical properties of natural products for successful drug formulation and delivery.
    References | Related Articles | Metrics
Current Issue
2023, Volume 13 Issue 4